tesevatinib (Q27089251)

From Wikidata

Jump to navigation Jump to search

chemical compound

KD-019
XL647
XL 647
N-(3,4-Dichloro-2-fluorophenyl)-6-methoxy-7-[[(3aalpha,5beta,6aalpha)-octahydro-2-methylcyclopenta[c]pyrrol-5-yl]methoxy]-4-quinazolinamine
EXEL-7647
TESEVATINIB
XL-647
Tesevatinib

Language	Label	Description	Also known as
English	tesevatinib	chemical compound	KD-019 XL647 XL 647 N-(3,4-Dichloro-2-fluorophenyl)-6-methoxy-7-[[(3aalpha,5beta,6aalpha)-octahydro-2-methylcyclopenta[c]pyrrol-5-yl]methoxy]-4-quinazolinamine EXEL-7647 TESEVATINIB XL-647 Tesevatinib

Statements

type of chemical entity

0 references

chemical compound

0 references

chemical structure

Tesevatinib skeletal.svg
512 × 304; 8 KB

0 references

490.13386±0 dalton

1 reference

language of work or name

XL-647 (English)

3 October 2016

490.1339±0 dalton

1 reference

language of work or name

TESEVATINIB (English)

14 October 2016

chemical formula

C₂₄H₂₅Cl₂FN₄O₂

1 reference

language of work or name

XL-647 (English)

3 October 2016

canonical SMILES

CN1CC2CC(CC2C1)COC3=C(C=C4C(=C3)N=CN=C4NC5=C(C(=C(C=C5)Cl)Cl)F)OC

1 reference

language of work or name

XL-647 (English)

3 October 2016

isomeric SMILES

CN1C[C@H]2CC(C[C@H]2C1)COC3=C(C=C4C(=C3)N=CN=C4NC5=C(C(=C(C=C5)Cl)Cl)F)OC

1 reference

language of work or name

XL-647 (English)

3 October 2016

physically interacts with

epidermal growth factor receptor

subject has role

reaction inhibitor

1 reference

Open Targets Platform

14 August 2023

https://platform.opentargets.org/drug/CHEMBL3544983

EPH receptor B4

subject has role

reaction inhibitor

1 reference

Open Targets Platform

14 August 2023

https://platform.opentargets.org/drug/CHEMBL3544983

Erb-b2 receptor tyrosine kinase 2

subject has role

reaction inhibitor

1 reference

Open Targets Platform

14 August 2023

https://platform.opentargets.org/drug/CHEMBL3544983

Commons category

Tesevatinib

0 references

Identifiers

InChI=1S/C24H25Cl2FN4O2/c1-31-9-14-5-13(6-15(14)10-31)11-33-21-8-19-16(7-20(21)32-2)24(29-12-28-19)30-18-4-3-17(25)22(26)23(18)27/h3-4,7-8,12-15H,5-6,9-11H2,1-2H3,(H,28,29,30)/t13?,14-,15+

1 reference

language of work or name

XL-647 (English)

3 October 2016

HVXKQKFEHMGHSL-GOOCMWNKSA-N

1 reference

language of work or name

XL-647 (English)

3 October 2016

CAS Registry Number

1 reference

Global Substance Registration System

language of work or name

tesevatinib (English)

14 October 2016

1 reference

language of work or name

tesevatinib (English)

14 October 2016

2 references

language of work or name

XL-647 (English)

3 October 2016

matched by identifier from

HVXKQKFEHMGHSL-GOOCMWNKSA-N

mapping relation type

0 references

1 reference

language of work or name

TESEVATINIB (English)

14 October 2016

2 references

based on heuristic

inferred from InChIKey

matched by identifier from

HVXKQKFEHMGHSL-GOOCMWNKSA-N

UniChem compound ID

1 reference

Guide to Pharmacology Ligand ID

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

language of work or name

XL-647 (English)

3 October 2016

reason for deprecated rank

cannot be confirmed by other sources

1 reference

Global Substance Registration System

language of work or name

tesevatinib (English)

14 October 2016

Probes And Drugs ID

0 references

Google Knowledge Graph ID

0 references

Sitelinks

Wikipedia(1 entry)

enwiki Tesevatinib

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(1 entry)

commonswiki Category:Tesevatinib

Retrieved from "https://www.wikidata.org/w/index.php?title=Q27089251&oldid=2258957713"